CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL
- 1 June 2011
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 35 (6) , 750-756
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research (NIHR)
This publication has 30 references indexed in Scilit:
- Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemiaBlood, 2010
- High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemiaClinical Immunology, 2009
- CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell SurvivalCancer Research, 2009
- CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemiaHaematologica, 2008
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialBritish Journal of Haematology, 2008
- Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemiaBlood, 2008
- CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentBlood, 2006
- CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulationLeukemia, 2005
- Expression of ZAP-70 Protein Correlates with Disease Stage in Chronic Lymphocytic Leukemia and is Associated with, but not Generally Restricted to, Non-mutated Ig VHStatusLeukemia & Lymphoma, 2004
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003